LON:EVG - Evgen Pharma Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 13.75 -1.50 (-9.84 %) (As of 10/18/2018 02:19 PM ET)Previous CloseGBX 15.25Today's RangeGBX 13.15 - GBX 14.5052-Week RangeGBX 12.15 - GBX 29.25Volume261,788 shsAverage Volume207,445 shsMarket Capitalization£11.63 millionP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileDiscussionAnalyst RatingsChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Evgen Pharma plc, a clinical stage drug development company, focuses on the treatment of cancer and neurological diseases. Its core technology is Sulforadex for synthesizing and stabilizing the naturally occurring compound sulforaphane. The company's lead product is SFX-01, a synthetic version of sulforaphane stabilised that is in Phase II clinical trials for the treatment of breast cancer and subarachnoid haemorrhage, as well as in preclinical stage for multiple sclerosis and clinical stage to treat prostate cancer. Evgen Pharma plc was founded in 2007 and is headquartered in Wilmslow, the United Kingdom. Receive EVG News and Ratings via Email Sign-up to receive the latest news and ratings for EVG and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical SymbolLON:EVG CUSIPN/A Webevgen.com Phone+44-151-7053532 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on Equity-97.50% Return on Assets-86.51% Miscellaneous Employees11 Outstanding Shares74,110,000Market Cap£11.63 million Evgen Pharma (LON:EVG) Frequently Asked Questions What is Evgen Pharma's stock symbol? Evgen Pharma trades on the London Stock Exchange (LON) under the ticker symbol "EVG." What price target have analysts set for EVG? 3 brokers have issued twelve-month price objectives for Evgen Pharma's stock. Their forecasts range from GBX 113 to GBX 113. On average, they anticipate Evgen Pharma's share price to reach GBX 113 in the next year. This suggests a possible upside of 721.8% from the stock's current price. View Analyst Price Targets for Evgen Pharma. What is the consensus analysts' recommendation for Evgen Pharma? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evgen Pharma in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evgen Pharma. Who are some of Evgen Pharma's key competitors? Some companies that are related to Evgen Pharma include Science in Sport (SIS), CV Sciences (CVSI), Aequus Pharmaceuticals (AQS), Shield Therapeutics (STX), EVIO (EVIO), Venture Life Group (VLG), ESSA Pharma (EPI), Mountain High Acquisitions (MYHI), Lattice Biologics (LBL), Premier Biomedical (BIEI), Santo Mining (SANP), Bausch Health Companies (BHC), Charlotte's Web (CWBHF), Choom (CHOOF) and Cosmos (COSM). Who are Evgen Pharma's key executives? Evgen Pharma's management team includes the folowing people: Dr. Stephen Franklin, CEO & Exec. DirectorMr. Richard Anthony Moulson, CFO & Exec. Director (Age 56)Sally Ross, Clinical Devel. OfficerMs. Liz Jenkins, Regulatory ConsultantDr. Thomas Morris, Consultant & Medical Advisor of Oncology How do I buy shares of Evgen Pharma? Shares of EVG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Evgen Pharma's stock price today? One share of EVG stock can currently be purchased for approximately GBX 13.75. How big of a company is Evgen Pharma? Evgen Pharma has a market capitalization of £11.63 million. Evgen Pharma employs 11 workers across the globe. What is Evgen Pharma's official website? The official website for Evgen Pharma is http://evgen.com/. How can I contact Evgen Pharma? Evgen Pharma's mailing address is The Colony 146 Brownlow Hill, Altrincham Road, WILMSLOW, SK9 4LY, United Kingdom. The company can be reached via phone at +44-151-7053532. MarketBeat Community Rating for Evgen Pharma (LON EVG)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 150 (Vote Outperform)Underperform Votes: 105 (Vote Underperform)Total Votes: 255MarketBeat's community ratings are surveys of what our community members think about Evgen Pharma and other stocks. Vote "Outperform" if you believe EVG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVG will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/18/2018 by MarketBeat.com StaffFeatured Article: How is the discount rate different from the Federal Funds rate?